Pricing and Reimbursement Decision for a Newly Listed Medicine
A pharmacy in Tirana, Albania, is part of the national reimbursement scheme. A new medicine, 'Cardioplus' (a fixed-dose combination for hypertension), has just been added to the reimbursement list at a reimbursed price of 1200 ALL per pack of 30 tablets. The pharmacy's acquisition cost from the wholesaler is 900 ALL per pack (excluding VAT). The pharmacy's maximum allowed mark-up for reimbursed medicines is 15% on the ex-factory price, and the reimbursement price is fixed. The pharmacy must also pay a 20% VAT on the retail price (which is included in the reimbursed price). The pharmacy dispenses 200 packs per month. The pharmacist is concerned about the financial viability because the reimbursement price may not cover costs.
1. Calculate the pharmacy's gross profit per pack and monthly gross profit for Cardioplus, assuming the reimbursement price is the final retail price (VAT inclusive) and the pharmacy cannot charge patients above this. Show your calculations and determine if the pharmacy makes a profit or loss.
Read the worked answer
Given:
- Reimbursed price (retail, VAT inclusive) = 1200 ALL.
- Acquisition cost = 900 ALL (excluding VAT).
- VAT rate = 20% on retail price.
- Mark-up regulation: maximum 15% on ex-factory price, but here the reimbursement price is fixed; we must check if the acquisition cost plus allowed mark-up exceeds the reimbursement price.
Step 1: Calculate the ex-factory price implied by the acquisition cost.
The pharmacy buys from wholesaler; the ex-factory price is not directly given. The mark-up is on ex-factory price, but the pharmacy's cost is wholesale price. For simplicity, assume the wholesaler's price includes wholesale margin; the pharmacy's allowed mark-up is on its acquisition cost? The problem states mark-up on ex-factory price, but we lack that. Alternatively, the reimbursement price is fixed, so the pharmacy's revenue per pack is 1200 ALL (VAT inclusive).
Step 2: Determine net revenue after VAT.
VAT = 20% of retail price = 0.20 × 1200 = 240 ALL.
Net revenue (excluding VAT) = 1200 − 240 = 960 ALL.
Step 3: Gross profit per pack.
Gross profit = Net revenue − Acquisition cost = 960 − 900 = 60 ALL per pack.
Step 4: Monthly gross profit.
60 ALL/pack × 200 packs = 12,000 ALL per month.
Conclusion: The pharmacy makes a gross profit of 60 ALL per pack (5% of net revenue) and 12,000 ALL per month. This is a positive margin, but low; after accounting for overhead (staff, rent), it may be insufficient. The pharmacist should verify if the 15% mark-up regulation applies differently; if the acquisition cost were higher, a loss could occur.
2. Discuss two strategies the pharmacy could use to improve the financial viability of dispensing Cardioplus while remaining compliant with pricing regulations and maintaining patient access.
Read the worked answer
1. Negotiate with wholesalers for better acquisition cost:
- The pharmacy can join group purchasing organizations (GPOs) or negotiate volume discounts with wholesalers. If the acquisition cost is reduced, the gross profit per pack increases. For example, a 5% discount (900 → 855 ALL) would increase gross profit to 105 ALL per pack (960 − 855), nearly doubling profit.
- Ensure compliance: any discount must be legitimate and not violate anti-kickback or transparency rules.
2. Optimize inventory and reduce waste:
- Cardioplus has a fixed reimbursement price; the pharmacy can minimize holding costs by ordering in quantities that match demand (200 packs/month) to avoid excess stock and expiry. Use just-in-time ordering if wholesaler delivery is reliable.
- Reduce dispensing errors and returns; each returned pack may not be fully reimbursed.
- Additionally, the pharmacy can counsel patients on adherence to reduce waste and improve health outcomes, which may indirectly support reimbursement negotiations.
3. Diversify revenue through enhanced services:
- Offer paid services (e.g., blood pressure monitoring) to generate additional income that offsets low margins on reimbursed medicines. This is allowed as long as it does not conflict with regulations.
Compliance note: Do not charge patients above the reimbursed price; that would violate the scheme. Focus on cost reduction and efficiency.